Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
artificial intelligence consultation

Generative AI explains echo results to heart patients

Researchers used OpenAI’s ChatGPT technology to build 100 patient-friendly echo reports, evaluating each one for accuracy, relevance and understandability. The AI reports passed the test with flying colors. 

doctor examines patient data on their tablet

FDA sees potential in new PET imaging agent for cardiac amyloidosis

Early evidence suggests a new PET imaging agent from California-based Attralus can help evaluate all varieties of systemic cardiac amyloidosis. It has now been granted the FDA's breakthrough therapy designation. 

Echocardiography vs CT for Prediction of Newly Created LVOT Area during TMVR

3D echo comparable to CT for predicting TMVR complications

LVOT obstruction after TMVR remains a significant concern among structural heart cardiologists. Predicting the risk of LVOT obstruction typically requires CT, which comes with certain disadvantages compared to other imaging options.

stroke brain dementia alzheimer's puzzle mental health

Stroke after TAVR in AFib patients: Key risk factors cardiologists should know

Reviewing a patient's medical history can help care teams select the optimal post-TAVR oral anticoagulation strategy.

Sahil Parikh, MD, FSCAI, Director of Endovascular Services at New York-Presbyterian Columbia University Irving Medical Center, and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explains there is scant clinical data on what the standard of care should be for pulmonary embolism, so it is up to clinicians to decide what is best for patients based on whether patients have mild to severe PE.

Pulmonary embolism treatments continue to evolve

There is still a lack of lack of standardized treatment protocols for pulmonary embolism. This is mainly due to limited data and a lack of reliable risk assessments, one specialist explained.

Anne Kroman, DO, PhD, director of lead management and the device clinic, and assistant professor at Medical University of South Carolina (MUSC), explains more women need to be included in clinical trials to help better understand sex differences in electrophysiology presentations.

Why electrophysiology trials need to include more women

Most EP clinical study data are from men, Anne Kroman, DO, explained in an interview. This is a significant problem, she said, because heart rhythm issues look quite different in women. 

Thumbnail

Pharmacists help lower stroke risk in patients with undiagnosed, undertreated AFib

Researchers described pharmacies as an “attractive setting for community-based AFib screening."

FibriCheck, a Belgium-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered digital platform that uses smartphone cameras to obtain heart rhythm measurements.

FDA clears heart rhythm AI that turns smartphones into medical devices

FibriCheck has been increasing its presence in the United States in anticipation of this approval, opening a new office and partnering with U.S. hospitals. 

Displaying 113 - 120 of 2622

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.